Other Species / Isoforms
  AATF (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S20-p
QLLNPRPsEADPEAD
0 2
AATF (human) QLLNPRPsEADPEAD S20-p
AATF (mouse) QLLNPRPREADPEAD R20
AATF (rat) QLLNPRPREADPEAD R20
S55-p
GDFLVVGsIRkLAsA
0 2
AATF (human) GDFLVVGsIRkLAsA S55-p
AATF (mouse) KDDLAVSSIRKLAPV S54
AATF (rat) EDDLPVSSIRKLAPV S54
K58-ub
LVVGsIRkLAsAsLL
0 1
AATF (human) LVVGsIRkLAsAsLL K58-ub
AATF (mouse) LAVSSIRKLAPVSLL K57
AATF (rat) LPVSSIRKLAPVSLL K57
K58-sm
LVVGsIRkLAsAsLL
0 1
AATF (human) LVVGsIRkLAsAsLL K58-sm
AATF (mouse) LAVSSIRKLAPVSLL K57
AATF (rat) LPVSSIRKLAPVSLL K57
S61-p
GsIRkLAsAsLLDtD
0 7
AATF (human) GsIRkLAsAsLLDtD S61-p
AATF (mouse) SSIRKLAPVSLLDTD P60
AATF (rat) SSIRKLAPVSLLDTD P60
S63-p
IRkLAsAsLLDtDkR
0 3
AATF (human) IRkLAsAsLLDtDkR S63-p
AATF (mouse) IRKLAPVSLLDTDKR S62
AATF (rat) IRKLAPVSLLDTDKR S62
T67-p
AsAsLLDtDkRYCGk
Upstream
0 3
Treatment
  • nocodazole
AATF (human) AsAsLLDtDkRYCGk T67-p
AATF (mouse) APVSLLDTDKRYSGK T66
AATF (rat) APVSLLDTDKRYSGK T66
K69-ub
AsLLDtDkRYCGkTT
0 3
AATF (human) AsLLDtDkRYCGkTT K69-ub
AATF (mouse) VSLLDTDKRYSGKTt K68
AATF (rat) VSLLDTDKRYSGKTT K68
K74-ub
tDkRYCGkTTSRKAW
0 1
AATF (human) tDkRYCGkTTSRKAW K74-ub
AATF (mouse) TDKRYSGKTtSRKAW K73
AATF (rat) TDKRYSGKTTSRKAW K73
T76
kRYCGkTTSRKAWNE
0 1
AATF (human) kRYCGkTTSRKAWNE T76
AATF (mouse) KRYSGKTtSRKAWKE T75-p
AATF (rat) KRYSGKTTSRKAWKE T75
S143-p
SKKSRSHsAktPGFs
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
  • protein stabilization
Effects on Biological Processes:
  • apoptosis, inhibited
  • transcription, altered
Kinase, in vitro:
  • Chk2 (human)
Treatment
  • adriamycin
AATF (human) SKKSRSHsAktPGFs S143-p
AATF (mouse) gap -
AATF (rat) gap -
K145-ub
KSRSHsAktPGFsVQ
0 1
AATF (human) KSRSHsAktPGFsVQ K145-ub
AATF (mouse) under review -
AATF (rat) under review -
T146-p
SRSHsAktPGFsVQs
0 5
AATF (human) SRSHsAktPGFsVQs T146-p
AATF (mouse) gap -
AATF (rat) gap -
S150-p
sAktPGFsVQsIsDF
0 2
AATF (human) sAktPGFsVQsIsDF S150-p
AATF (mouse) gap -
AATF (rat) gap -
S153-p
tPGFsVQsIsDFEkF
0 6
AATF (human) tPGFsVQsIsDFEkF S153-p
AATF (mouse) gap -
AATF (rat) gap -
S155-p
GFsVQsIsDFEkFTK
0 9
AATF (human) GFsVQsIsDFEkFTK S155-p
AATF (mouse) gap -
AATF (rat) gap -
K159-ub
QsIsDFEkFTKGMDD
0 5
AATF (human) QsIsDFEkFTKGMDD K159-ub
AATF (mouse) gap -
AATF (rat) gap -
S189-p
EGDDAEDsQGEsEED
Upstream
Downstream
1 4
Effects on Modified Protein
  • molecular association, regulation
  • protein stabilization
Effects on Biological Processes:
  • apoptosis, inhibited
  • transcription, altered
Kinase, in vitro:
  • ATM (human)
Treatment
  • adriamycin
AATF (human) EGDDAEDsQGEsEED S189-p
AATF (mouse) SEDVEEDLEGEDEED L156
AATF (rat) SEDVEEDLEGEDEED L153
S193-p
AEDsQGEsEEDRAGD
0 4
AATF (human) AEDsQGEsEEDRAGD S193-p
AATF (mouse) EEDLEGEDEEDREED D160
AATF (rat) EEDLEGEDEEDREED D157
S203-p
DRAGDRNsEDDGVVM
0 25
AATF (human) DRAGDRNsEDDGVVM S203-p
AATF (mouse) DREEDRNsEDDGVVA S170-p
AATF (rat) DREEDRNSEDDGVVM S167
S213-p
DGVVMTFsSVKVsEE
0 1
AATF (human) DGVVMTFsSVKVsEE S213-p
AATF (mouse) DGVVAAFSSVKVSEE S180
AATF (rat) DGVVMAFSGVKVSEE S177
S218-p
TFsSVKVsEEVEkGR
0 1
AATF (human) TFsSVKVsEEVEkGR S218-p
AATF (mouse) AFSSVKVSEEVEKGR S185
AATF (rat) AFSGVKVSEEVEKGR S182
K223-sm
KVsEEVEkGRAVkNQ
0 1
AATF (human) KVsEEVEkGRAVkNQ K223-sm
AATF (mouse) KVSEEVEKGRAVKNQ K190
AATF (rat) KVSEEVEKGRAVKNQ K187
K228-ub
VEkGRAVkNQIALWD
0 4
AATF (human) VEkGRAVkNQIALWD K228-ub
AATF (mouse) VEKGRAVKNQIALWD K195
AATF (rat) VEKGRAVKNQIALWD K192
K246-ub
EGRIKLQkALLTtNQ
Upstream
0 5
Treatment
  • MG132
AATF (human) EGRIKLQkALLTtNQ K246-ub
AATF (mouse) EGRIKLQKALLTTNQ K213
AATF (rat) EGRIKLQKALLTTNQ K210
T251-p
LQkALLTtNQLPQPD
0 1
AATF (human) LQkALLTtNQLPQPD T251-p
AATF (mouse) LQKALLTTNQLPQPD T218
AATF (rat) LQKALLTTNQLPQPD T215
K264-ub
PDVFPLFkDkGGPEF
0 2
AATF (human) PDVFPLFkDkGGPEF K264-ub
AATF (mouse) PDVFPVFKDKGGPEF K231
AATF (rat) PDVFPVFKDKGGPEF K228
K266-ub
VFPLFkDkGGPEFSs
0 5
AATF (human) VFPLFkDkGGPEFSs K266-ub
AATF (mouse) VFPVFKDKGGPEFAS K233
AATF (rat) VFPVFKDKGGPEFAS K230
S273-p
kGGPEFSsALkNSHK
0 3
AATF (human) kGGPEFSsALkNSHK S273-p
AATF (mouse) KGGPEFASALKNSHK S240
AATF (rat) KGGPEFASALKNSHK S237
K276-ub
PEFSsALkNSHKALK
0 1
AATF (human) PEFSsALkNSHKALK K276-ub
AATF (mouse) PEFASALKNSHKALK K243
AATF (rat) PEFASALKNSHKALK K240
K276-m1
PEFSsALkNSHKALK
0 1
AATF (human) PEFSsALkNSHKALK K276-m1
AATF (mouse) PEFASALKNSHKALK K243
AATF (rat) PEFASALKNSHKALK K240
S288-p
ALKALLRsLVGLQEE
0 1
AATF (human) ALKALLRsLVGLQEE S288-p
AATF (mouse) ALKALLRSLVDLQEE S255
AATF (rat) ALKALLRSLVDLQEE S252
Y305-p
FQYPDTRyLVDGtKP
0 1
AATF (human) FQYPDTRyLVDGtKP Y305-p
AATF (mouse) FQYPDTRHIVNGAKP H272
AATF (rat) FQYPDTRYLVKGTKP Y269
T310-p
TRyLVDGtKPNAGsE
0 2
AATF (human) TRyLVDGtKPNAGsE T310-p
AATF (mouse) TRHIVNGAKPNtEsE A277
AATF (rat) TRYLVKGTKPNAEsE T274
A314
VDGtKPNAGsEEIss
0 2
AATF (human) VDGtKPNAGsEEIss A314
AATF (mouse) VNGAKPNtEsEEIss T281-p
AATF (rat) VKGTKPNAEsEEIss A278
S316-p
GtKPNAGsEEIssED
Upstream
0 50
Treatment
  • nocodazole
AATF (human) GtKPNAGsEEIssED S316-p
AATF (mouse) GAKPNtEsEEIssED S283-p
AATF (rat) GTKPNAEsEEIssED S280-p
S320-p
NAGsEEIssEDDELV
Upstream
0 58
Regulatory protein:
  • PLK1 (human)
Treatment
  • nocodazole
AATF (human) NAGsEEIssEDDELV S320-p
AATF (mouse) NtEsEEIssEDDELV S287-p
AATF (rat) NAEsEEIssEDDELV S284-p
S321-p
AGsEEIssEDDELVE
Upstream
0 58
Regulatory protein:
  • PLK1 (human)
Treatment
  • nocodazole
AATF (human) AGsEEIssEDDELVE S321-p
AATF (mouse) tEsEEIssEDDELVG S288-p
AATF (rat) AEsEEIssEDDELVG S285-p
K342-ub
RRVPAKRkLEMEDYP
0 3
AATF (human) RRVPAKRkLEMEDYP K342-ub
AATF (mouse) RKAPPKRKLEMEDyP K308
AATF (rat) RKAPPKRKLEMEDYP K305
K342-sm
RRVPAKRkLEMEDYP
0 1
AATF (human) RRVPAKRkLEMEDYP K342-sm
AATF (mouse) RKAPPKRKLEMEDyP K308
AATF (rat) RKAPPKRKLEMEDYP K305
Y348
RkLEMEDYPSFMAkR
0 1
AATF (human) RkLEMEDYPSFMAkR Y348
AATF (mouse) RKLEMEDyPsFMAkR Y314-p
AATF (rat) RKLEMEDYPSFMAKR Y311
S350
LEMEDYPSFMAkRFA
0 1
AATF (human) LEMEDYPSFMAkRFA S350
AATF (mouse) LEMEDyPsFMAkRFA S316-p
AATF (rat) LEMEDYPSFMAKRSA S313
K354
DYPSFMAKRFADFTV
0 1
AATF (human) DYPSFMAKRFADFTV K354
AATF (mouse) DyPsFMAkRFADFTI K320-ac
AATF (rat) DYPSFMAKRSADFTV K317
K354-ub
DYPSFMAkRFADFTV
0 2
AATF (human) DYPSFMAkRFADFTV K354-ub
AATF (mouse) DyPsFMAKRFADFTI K320
AATF (rat) DYPSFMAKRSADFTV K317
T366-p
FTVYRNRtLQkWHDK
Upstream
Downstream
1 1
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • apoptosis, inhibited
Kinase, in vitro:
  • MAPKAPK2 (human)
Putative in vivo kinases:
  • MAPKAPK2 (human)
AATF (human) FTVYRNRtLQkWHDK T366-p
AATF (mouse) FTIYRNHTLQKWHDK T332
AATF (rat) FTVYRNRTLQKWHDK T329
K369-ac
YRNRtLQkWHDKTKL
0 1
AATF (human) YRNRtLQkWHDKTKL K369-ac
AATF (mouse) YRNHTLQKWHDKTKL K335
AATF (rat) YRNRTLQKWHDKTKL K332
K380-ac
KTKLASGkLGkGFGA
0 1
AATF (human) KTKLASGkLGkGFGA K380-ac
AATF (mouse) KTKLASGKLGKGFGA K346
AATF (rat) KTKLASGKLGKGFGA K343
K383-ac
LASGkLGkGFGAFER
0 3
AATF (human) LASGkLGkGFGAFER K383-ac
AATF (mouse) LASGKLGKGFGAFER K349
AATF (rat) LASGKLGKGFGAFER K346
K383-ub
LASGkLGkGFGAFER
0 5
AATF (human) LASGkLGkGFGAFER K383-ub
AATF (mouse) LASGKLGKGFGAFER K349
AATF (rat) LASGKLGKGFGAFER K346
S391-p
GFGAFERsILTQIDH
0 1
AATF (human) GFGAFERsILTQIDH S391-p
AATF (mouse) GFGAFERSILTQIDH S357
AATF (rat) GFGAFERSILTQIDH S354
K403-ub
IDHILMDkERLLRRt
0 3
AATF (human) IDHILMDkERLLRRt K403-ub
AATF (mouse) IDHIMMDKERLLRRT K369
AATF (rat) IDHILMDKERLLRRT K366
T410-p
kERLLRRtQtKRSVY
0 1
AATF (human) kERLLRRtQtKRSVY T410-p
AATF (mouse) KERLLRRTQTKRSAY T376
AATF (rat) KERLLRRTQTKRSAY T373
T412-p
RLLRRtQtKRSVYRV
0 1
AATF (human) RLLRRtQtKRSVYRV T412-p
AATF (mouse) RLLRRTQTKRSAYRV T378
AATF (rat) RLLRRTQTKRSAYRV T375
K422-ub
SVYRVLGkPEPAAQP
0 2
AATF (human) SVYRVLGkPEPAAQP K422-ub
AATF (mouse) SAYRVLGKPEPVPEP K388
AATF (rat) SAYRVLGKPEPVPEP K385
K422-sm
SVYRVLGkPEPAAQP
0 1
AATF (human) SVYRVLGkPEPAAQP K422-sm
AATF (mouse) SAYRVLGKPEPVPEP K388
AATF (rat) SAYRVLGKPEPVPEP K385
K451-ub
APANAHLkDLDEEIF
0 1
AATF (human) APANAHLkDLDEEIF K451-ub
AATF (mouse) GPANAHLRDLDEEIF R417
AATF (rat) VPANAHLKDLDEEIF K414
K475-ub
LRELIERkTsSLDPN
0 4
AATF (human) LRELIERkTsSLDPN K475-ub
AATF (mouse) LRELIERKTSSLDPN K441
AATF (rat) LRELIERKTSSLDPN K438
K475-sm
LRELIERkTsSLDPN
0 1
AATF (human) LRELIERkTsSLDPN K475-sm
AATF (mouse) LRELIERKTSSLDPN K441
AATF (rat) LRELIERKTSSLDPN K438
S477-p
ELIERkTsSLDPNDQ
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
  • protein stabilization
Effects on Biological Processes:
  • apoptosis, inhibited
  • transcription, altered
Kinase, in vitro:
  • Chk2 (human)
Treatment
  • adriamycin
AATF (human) ELIERkTsSLDPNDQ S477-p
AATF (mouse) ELIERKTSSLDPNDQ S443
AATF (rat) ELIERKTSSLDPNDQ S440
K496-ub
RQWLAIQkLRSKIHK
0 3
AATF (human) RQWLAIQkLRSKIHK K496-ub
AATF (mouse) RQWLAIQKLRSKIRK K462
AATF (rat) RQWLAIQKLRSKIRK K459
S510-p
KKVDRKAsKGRKLRF
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
  • protein stabilization
Effects on Biological Processes:
  • apoptosis, inhibited
  • transcription, altered
Kinase, in vitro:
  • Chk2 (human)
Treatment
  • adriamycin
AATF (human) KKVDRKAsKGRKLRF S510-p
AATF (mouse) KKVDRKASKGRKLRF S476
AATF (rat) KKVDRKASKGRKLRF S473